Glenmark Pharmaceuticals board to consider Unaudited Financial Results

14 Jan 2014 Evaluate

Glenmark Pharmaceuticals has informed that a meeting of the Board of Directors of the company will be held on January 24, 2014, to consider and approve the Company Un-audited Financial Statements for the Third Quarter ended December 31, 2013.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1540.45 -52.45 (-3.29%)
10-Jan-2025 15:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1788.15
Dr. Reddys Lab 1355.50
Cipla 1469.95
Lupin 2191.35
Zydus Lifesciences 1004.00
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.